BDNF may be involved in the development of chemotherapy-induced peripheral neuropathy (CIPN), and its blood concentration is inversely correlated with the severity of bortezomib-induced neuropathy (11, 12). The gene discussed is BDNF; the disease is peripheral neuropathy.